BioNexus Gene Lab (BGLC) announced a strategic partnership with ML Tech to optimize the BGLC’s Ethereum-based growth ...

BioNexus Gene Lab Corporation, a leading medical laboratory services provider, has made history by becoming the first ...

BioNexus Gene Lab board of directors has officially approved the Ethereum-focused treasury strategy, alongside an ETH ...

BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in the digital and healthcare space, has announced a strategic partnership with ML Tech to optimize the BGLC’s ...

BioNexus Gene Lab (BGLC) (ISIN: US0906282076)股票专题，提供今日BioNexus Gene Lab(BGLC) (ISIN: US0906282076)股票最新股价查询，实时市场行情，走势图表，及BioNexus Gene Lab Corp(BGLC) (ISIN: ...

Board of Directors has formally approved the Company’s new Ethereum (ETH)-focused treasury strategy. Concurrently, ...

吉隆坡 - 纳斯达克上市医疗科技公司BioNexus Gene Lab Corp. (NASDAQ: BGLC)，市值588万美元，年收入926万美元，最近在其财务管理方面做出战略性调整，正式批准将以太坊 (ETH)作为其主要财务资产。这一举措使BGLC成为纳斯达克交易所首家专注于以太坊进行财务管理的公司。根据 InvestingPro ...

KUALA LUMPUR, Malaysia, March 08, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in the digital and healthcare space, has announced a ...

吴说获悉，医疗科技公司 BioNexus Gene Lab 董事会已批准以太坊（ETH）为核心的财务储备战略，成为首家专注于以太坊的纳斯达克上市公司。BGLC 同时发布《以太坊战略白皮书》，阐述该决策的依据，并分析以太坊在机构采用、权益证明（PoS）质押收益、稳定币交易及即将升级的 Pectra 协议等方面的作用。